Paper9720515
Prognostic markers in bladder cancer: a contemporary review of the literature.
Stein JP and 7 others. J Urol, 1998. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Prognostic markers in bladder cancer: a contemporary review of the literature. Papers, record 9720515. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9720515
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Transitional Cell | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Antigens, Neoplasm | |
| Biomarkers, Tumor | |
| Cell Adhesion Molecules | |
| Cell Cycle Proteins | |
| Epidermal Growth Factor | |
| Forecasting | |
| Humans | |
| Neovascularization, Pathologic | |
| Oncogenes | |
| Prognosis |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39628486 | Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host? | Front Immunol | 2024 | https://conductscience.org/library/papers/39628486 | PubMed |
| 30112441 | Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study. | Bladder Cancer | 2018 | https://conductscience.org/library/papers/30112441 | PubMed |
| 29671787 | Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29671787 | PubMed |
| 29667104 | Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study. | Cancer Causes Control | 2018 | https://conductscience.org/library/papers/29667104 | PubMed |
| 28260746 | Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules. | Med Sci Monit | 2017 | https://conductscience.org/library/papers/28260746 | PubMed |
| 27440446 | Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway. | Cancer Sci | 2016 | https://conductscience.org/library/papers/27440446 | PubMed |
| 26955879 | Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy. | BMC Complement Altern Med | 2016 | https://conductscience.org/library/papers/26955879 | PubMed |
| 26279824 | New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer. | Korean J Urol | 2015 | https://conductscience.org/library/papers/26279824 | PubMed |
| 25866762 | Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25866762 | PubMed |
| 25521854 | Met in urological cancers. | Cancers (Basel) | 2014 | https://conductscience.org/library/papers/25521854 | PubMed |
| 25391391 | Immunological basis in the pathogenesis and treatment of bladder cancer. | Expert Rev Clin Immunol | 2015 | https://conductscience.org/library/papers/25391391 | PubMed |
| 24359437 | Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis. | BMC Complement Altern Med | 2013 | https://conductscience.org/library/papers/24359437 | PubMed |
| 24353313 | Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells. | Mol Pharmacol | 2014 | https://conductscience.org/library/papers/24353313 | PubMed |
| 23653844 | Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer. | Iran J Basic Med Sci | 2012 | https://conductscience.org/library/papers/23653844 | PubMed |
| 22207109 | Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells. | Med Sci Monit | 2012 | https://conductscience.org/library/papers/22207109 | PubMed |
| 21881030 | A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21881030 | PubMed |
| 20803103 | Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. | Med Oncol | 2011 | https://conductscience.org/library/papers/20803103 | PubMed |
| 19707309 | Targeted therapies in the management of metastatic bladder cancer. | Biologics | 2007 | https://conductscience.org/library/papers/19707309 | PubMed |
| 19591789 | Comparative analysis of protein-protein interactions in cancer-associated genes. | Genomics Proteomics Bioinformatics | 2009 | https://conductscience.org/library/papers/19591789 | PubMed |
| 19228380 | Expression of Bmi-1 is a prognostic marker in bladder cancer. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19228380 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9720515
GET https://conductscience.org/api/papers/v1/9720515/cited_by?page=2